Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-05-14
2000-01-25
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, 514 4, 514 21, 530399, 530303, 530324, A61K 3830
Patent
active
06017885&
ABSTRACT:
IGF and IGFBP are administered to stimulate new bone formation in subjects with bone loss due to bone marrow disorders, connective tissue disorders, drugs, pregnancy, lactation, chronic hypophosphatemia, hyperphosphatasia, insulin-dependent diabetes mellitus, anorexia nervosa, cadmium poisoning, juvenile osteoporosis, Paget's disease of bone, osteoarthritis and periodontal disease. IGF-I and IGFBP-3 are optionally combined with agents that inhibit bone resorption.
REFERENCES:
patent: 5118667 (1992-06-01), Adams et al.
patent: 5187151 (1993-02-01), Clark et al.
patent: 5200509 (1993-04-01), Spencer et al.
patent: 5614496 (1997-03-01), Dunstan et al.
Blum et al., "Plasma IGFBP-3 levels as clinical indicators" Modern Concepts of Insulin-Like Growth Factors (1991) E.M. Spencer, ed., Elsevier, New York, pp. 381-393.
Wood et al., "Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein" Mol. Endocrin. (1988) 2:1176-1185.
Spratt et al., "Cloning and expression of human insulin-like growth factor binding protein 3" Growth Factors (1990) 3:63-72.
Martin et al., "Insulin-like growth factor-binding protein from human plasma. Purification and characterization" J. Biol. Chem. (1986) 261:8754-8760.
Sommer et al., "Molecular genetics and actions of recombinant insulin-like growth factor binding protein-3" Modern Concepts of Insulin-Like Growth Factors (1991) E.M. Spencer, ed., Elsevier, New York, pp. 715-728.
Shimasaki et al., "Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6)" Prog. Growth Factor Res. (1991) 3:243-266.
Spencer et al. "In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats" Bone (1991) 12:21-26.
Tobias et al., "Opposite effects of insulin-like growth factor-I on the formation of trabecular and cortical bone in adult female rats" Endocrinology (1992) 131:2387-2392.
Frost, "The pathomechanics of osteoporoses" Clin. Orthop. Rel. Res. (1985) 200:198-225.
Parfitt, "Age-related structural changes in trabecular and cortical bone: Cellular mechanisms and biomechanical consequences" Calcif. Tissue Int. (1984) 36:S123-S128.
Brewer et al., "Cloning, characterization, and expression of a human insulin-like growth factor binding protein" Biochem. Biophys. Res. Comm. (1988) 152:1289-1297.
Binkert et al., "Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2)" EMBO J. (1989) 8:2497-2502.
Shimasaki et al., "Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human" Mol. Endocrinol. (1990) 4:1451-1458.
Shimasaki et al., "Isolation and molecular cloning of insulin-like growth factor-binding protein-6" Mol. Endocrinol. (1991) 5:938-948.
Shimasaki et al., "Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human" J. Biol. Chem. (1991) 266:10646-10653.
Frost, Bone Histomorphometry: Techniques and Interpretation, R.R. Recker, ed., (1983) Boca Raton, FL. Chapter 4, pp. 37-52.
Wronski et al., "Skeletal alterations in ovariectomized rats" Calcif. Tissue Int. (1985) 37:324-328.
Kimmel et al., "Nondestructive measurement of bone mineral in femurs from ovariectomized rats" Calcif. Tissue Int. (1990) 46:101-110.
Durbridge et al., "Progressive cancellous bone loss in rats after adrenalectomy and oophorectomy" Calcif. Tissue Int. (1990) 47:383-387.
Miller et al., "Calcium absorption and osseous organ-, tissue-, and envelope-specific changes following ovariectomy in rats" Bone (1991) 12:439-446.
Wronski et al., "Temporal relationship between bone loss and increased bone turnover in ovariectomized rats" Calcif. Tissue Int. (1985) 43:179-183.
Turner et al., "The effects of ovariectomy and 17J-estradiol on cortical bone histomorphometry in growing rats" J. Bone & Mineral Res. (1987) 2:115-122.
Wronski et al., "Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats" Endocrinology (1988) 123:681-686.
Wronski et al., "Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats" Endocrinology (1989) 125:810-816.
Pfeilshifter et al., "Modulation of type J transforming growth factor activity in bone cultures by osteotropic hormones" Proc. Natl. Acad. Sci. U.S.A. (1987) 84:2024-2028.
Bagi, C.M. et al., "Benefit of Systemically Administered rhIGF-I and rhIGF-I/IGFBP-3 on Cancellous Bone in Ovariectomized Rats" J. Bone Mineral Res. 9(8):1301-1312 (1994).
Bagi, C.M. et al., "The rhIGF-I/IGFBP-3 Complex Stimulates Bone Formation on Cortical and Trabecular Surfaces in the Femoral Neck of Ovariectomized Rats" Bone and Mineral 25(1):S5 Abstract No. 12 (1994).
Turner et al., "Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats" Endocrinology (1988) 122:1146-1150.
Fisher et al., "Inhibition of osteoclastic bone resorption in vivo by echistatin, an `arginyl-glycyl-aspartyl` (RGD)-containing protein" Endocrinology (1993) 132:1411-1413.
Zaidi et al., "Inhibitors of bone resorption and implications for therapy" Curr. Opin. Therapeutic Patents (1992) 10:1517-1538.
Gunness-Hey, "Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone" Metab. Bone Dis. & Rel. Res. (1984) 5:177-181.
Jamall et al., "A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues" Analyt. Biochem. (1981) 112:70-75.
Miller et al., "Changes in bone mineral and bone formation rates during pregnancy and lactation in rats" Bone (1986) 7:283-287.
Miller et al., "Long-term osteopenic changes in cancellous bone structure in ovariectomized rats" Anat. Record (1993) 236:433-441.
Bagi et al., "Comparison of osteopenic changes in cancellous bone induced by ovariectomy and/or immobilization in adult rats" Anat. Record (1994) 239:243-254.
Parfitt et al., "Bone histomorphometry: Standardization of nomenclature, symbols, and units" J. Bone & Mineral Res. (1987) 2:595-610.
Studier et al., "Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes" J. Mol. Biol. (1986) 189:113-130.
Squires et al., "Production and characterization of human basic fibroblast growth factor from Escherichia coli" J. Biol. Chem. (1988) 263:16297-16302.
Meacock et al., "Partitioning of bacterial plasmids during cell division: a cis-acting locus that accomplishes stable plasmid inheritance" Cell (1980) 20:529-542.
Daughaday et al., Endocrine Reviews, vol. 10, No. 1, 68-91, 1989.
Rosen et al., Minireview, IGF's and Osteoporosis, 83-96, P.S.E.B.M., vol. 206, 1994.
Adams Steven W.
Bagi Cedo Martin
Brommage Robert
Rosen David M.
Celtrix Pharmaceuticals Inc.
Moezie F. T.
LandOfFree
IGF/IGFBP complex for promoting bone formation and for regulatin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IGF/IGFBP complex for promoting bone formation and for regulatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IGF/IGFBP complex for promoting bone formation and for regulatin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2315980